Moderatorzy: Estraven, Moderatorzy
mziel52 pisze:koty dostają profilaktycznie laktoferynę,
alinkaka pisze:mziel52 pisze:koty dostają profilaktycznie laktoferynę,
Ale to jest ludzkie a ja czytam ,że to co dla ludzi i psa nie nadaje się dla kota
mziel52 pisze:Jedna klamerka to czasem za mało, spróbuj dwie, jedna za drugą.
mziel52 pisze:... Obecnie cztery moje zdrowe koty dostają profilaktycznie laktoferynę, jedną kapsułkę lub saszetkę rozpuszczam w 8 ml i po kolei strzykam po 2 ml do mordek. Działa łagodząco na przewód pokarmowy (mam jednego kota rzygacza-wrzodowca), podnosi odporność, i podobno przeciwdziała i pomaga przy chłoniakach. Jest przy tym nieszkodliwa.
magdalena99 pisze:Bardzo proszę o informację, gdzie można poczytać o stosowaniu laktoferyny u kotów. Mam kotkę z chłoniakiem, więc interesuje mnie szczególnie ten aspekt.
8. Cancer Prevention
I0127. The present inventors have found that lactoferrin in
combination with at least one anti-tumour food factor is able
to inhibit tumour formation and inhibit tumour growth.
Lactoferrin, particularly metal ion lactoferrin releases anti
tumour factors such as T-cells and/or NK (natural killer) cells
and apoptosis-inducing factors into systemic circulation, dis
plays immune enhancing activity, anti-angiogenic activity
and direct tumour cytotoxicity, and is able to induce apoptosis
of tumour cells as shown in the examples below. It is believed
that any functional variant or functional fragment of lactof
errin in combination with at least one anti-tumour food factor
will exhibit similar activity as a lactoferrin in combination
with at least one anti-tumour food factor.
I0128. The present invention has utility in preventing can
cer, particularly in preventing relapse (tumour growth) after
Surgery such as often results from growth and proliferation of
secondary tumours, preventing tumour spread after diagnosis
and preparing subjects for administration of an anti-tumour
agent or anti-tumour therapy.
0129. Solid tumours must form new blood vessels before
they are able to grow beyond a certain size. Therefore, inhib
iting angiogenesis, particularly tumour angiogenesis (blood
vessel formation to Supply tumours) has clear applications in
treating cancer (Dass, 2004). As shown in the Examples
below, orally administered metal ion lactoferrin and at least
one anti-tumour food factor are able to significantly reduce
the number of vessels in tumours and significantly reduce
blood flow.
0.130 Inhibiting angiogenesis also has applications in
other disorders including but not limited to cardiovascular
diseases (atherosclerosis and restenosis for example), chronic
inflammation (rheumatoid arthritis, osteoarthritis, and
Crohn's disease for example), diabetes (diabetic retinopathy),
psoriasis, endometriosis, macular degeneration and adipos
ity. Therefore, lactoferrin or a functional variant or functional
fragment thereof and at least one anti-tumour food factor have
applications outside of cancer treatment and prevention.
I0131 Similarly, orally administered metal ion lactoferrin
and at least one anti-tumour food factor are able to induce
apoptosis of tumour cells, as shown in the Examples below.
0.132. Therefore, the present invention also relates to
methods of inhibiting tumourformationina Subject, inducing
apoptosis in a subject, inducing apoptosis of tumour cells in a
Subject, inhibiting angiogenesis in a subject and inhibiting
tumour angiogenesis in a subject comprising administration
of lactoferrin or a metal ion functional valiant or functional
fragment thereof to the subject.
I0133. In one embodiment the subject is susceptible to
cancer. In one embodiment the Subject has a tumour refrac
tory to therapy with a chemotherapeutic, anti-angiogenic or
immunotherapeutic agent. In one embodiment the Subject has
previously undergone unsuccessful therapy with a chemo
therapeutic, anti-angiogenic or immunotherapeutic agent.
magdalena99 pisze:mziel52 bardzo dziękuję za wyczerpującą odpowiedź
Jeszcze tylko upewnię się o dawkę. Rozumiem że podajesz dziennie 1/5 kapsułki 100 mg, czyli 20 mg?
Użytkownicy przeglądający ten dział: Brak zidentyfikowanych użytkowników i 384 gości